Literature DB >> 23732575

Cell therapy for lung disease: a step forward.

Jeffrey E Gotts1, Michael A Matthay2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23732575     DOI： 10.1378/chest.12-2993

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration.

Authors:  Zhongwei Cao; Raphael Lis; Ilias I Siempos; Shahin Rafii; Deebly Chavez; Koji Shido; Sina Y Rabbany; Bi-Sen Ding
Journal:  Nat Cell Biol       Date:  2015-01-26       Impact factor: 28.824

Review 2.  Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Authors:  Nadim Srour; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

Review 3.  Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?

Authors:  Nurdan Kokturk; Fatma Yıldırım; Pınar Yıldız Gülhan; Yeon Mok Oh
Journal:  Am J Stem Cells       Date:  2018-08-01

4.  Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways.

Authors:  Wen Gu; Lin Song; Xiao-Ming Li; Di Wang; Xue-Jun Guo; Wei-Guo Xu
Journal:  Sci Rep       Date:  2015-03-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.